ITGAX and cancer: Recruitment of CD11c+ dendritic cells has been shown to occur upon the release of damage-associated molecular patterns (DAMPs) by dying cancer cells, and can trigger antigen uptake, maturation and presentation, via recognition by the TLR4 and activation of the type I interferon pathway.